glp 1 agonist heart disease GLP-1RA in Different HFpEF Phenotypes Heart transplantation in the GLP-1
Description
It is clinical suitability, safety and long-term outcomes
2024 Jul 25;391(4):311-319.10.1056/NEJMoa2401755 [DOI] [PubMed] 42.Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, et al
The introduction of an injectable GLP-1 has opened up new possibilities for patients with type 2 diabetes and obesity
By 2030, over 30 million U.S
